MNOV Stock Analysis: Buy, Sell, or Hold?
MNOV - Medicinova, Inc.
$1.72
-0.03 (-1.71%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 18, 2026
16d
Get Alerted When MNOV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MNOV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MNOV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MNOV is currently trading at $1.72, which is considered slightly high relative to its 30-day fair value range of $1.33 to $1.73.
Technical Outlook: Technically, MNOV is in a strong uptrend. Immediate support is located at $1.55, while resistance sits at $1.92.
Market Sentiment: MNOV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.00 (+481.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MNOV is in a strong uptrend. Immediate support is located at $1.55, while resistance sits at $1.92.
Market Sentiment: MNOV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.00 (+481.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$1.33 -
$1.73
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
Protect Your Profits
Holding MNOV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 481.4% below Wall St target ($10.00)
- CAUTION: Recommendation downgraded due to -7.5% 5-day decline
Fair Price Analysis
30-Day Fair Range
$1.33 -
$1.73
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.55
Resistance Level
$1.92
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-5.38
Wall Street Target
$10.00
(+481.4%)
Last updated: February 01, 2026 9:55 AM ET
Data refreshes hourly during market hours. Next update: 10:55 AM
Data refreshes hourly during market hours. Next update: 10:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MNOV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$477 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$514 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$847 | 52 HOLD |
Advanced MNOV Option Strategies
Professional options setups generated by AI based on today's MNOV price and gamma walls.
